Lates News

date
16/01/2026
US stock weight loss drug sector under pressure, Lilly dropped more than 5%, the company's weight loss drug was included in the FDA review list, decision delayed until April 10, 2026; Novo Nordisk fell more than 4%, Pfizer, and Amgen fell more than 1%.
Latest
See all latestmore